메뉴 건너뛰기




Volumn 100, Issue 3, 2007, Pages 485-486

Outcomes for radiation therapy after radical prostatectomy for prostate cancer: What really matters?

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; PROSTATE SPECIFIC ANTIGEN;

EID: 34547613701     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2007.07057.x     Document Type: Note
Times cited : (2)

References (9)
  • 1
    • 23744493443 scopus 로고    scopus 로고
    • Postoperative radiotherapy after radical prostatectomy: A randomized controlled trial (EORTC Trial 22911)
    • Bolla M, Van Poppel H, Collette L et al. Postoperative radiotherapy after radical prostatectomy: a randomized controlled trial (EORTC Trial 22911). Lancet 2005 366 : 572 8
    • (2005) Lancet , vol.366 , pp. 572-8
    • Bolla, M.1    Van Poppel, H.2    Collette, L.3
  • 2
    • 34547614168 scopus 로고    scopus 로고
    • on behalf or EORTC Genito-Urinary and Radiation Oncology Groups. ASCO 2007 Prostate Cancer Symposium, Orlando, Florida, February 22-24
    • Bolla M, Van Poppel H, Collette L, van der Kwast TH on behalf or EORTC Genito-Urinary and Radiation Oncology Groups. ASCO 2007 Prostate Cancer Symposium, Orlando, Florida, February 22-24, 2007
    • (2007)
    • Bolla, M.1    Van Poppel, H.2    Collette, L.3    Van Der Kwast, T.H.4
  • 3
    • 5444248630 scopus 로고    scopus 로고
    • Bicalutamide 150 MG in addition to standard care in patients with localized or locally advanced prostate cancer. results from the second analysis of the early prostate cancer program at median follow up of 5.4 years
    • Wirth MP, See WA, McLeod DG et al. Bicalutamide 150 MG in addition to standard care in patients with localized or locally advanced prostate cancer. results from the second analysis of the early prostate cancer program at median follow up of 5.4 years. J Urol 2004 172 : 1865 70
    • (2004) J Urol , vol.172 , pp. 1865-70
    • Wirth, M.P.1    See, W.A.2    McLeod, D.G.3
  • 4
    • 34547619333 scopus 로고    scopus 로고
    • FDA Statement. Pfizer stops all torcetrapib clinical trials in interest of patient safety. Available at. Accessed May 2007
    • FDA Statement. Pfizer stops all torcetrapib clinical trials in interest of patient safety December 3, 2006 Available at http://www.fda.gov/bbs/topics/ NEWS/2006/NEW01514.html Accessed May 2007
    • (2006)
  • 5
    • 0023243140 scopus 로고
    • Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathologic stage II testicular cancer
    • Williams SD, Stablein DM, Einhorn LH et al. Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathologic stage II testicular cancer. N Eng J Med 1987 317 : 1433 8
    • (1987) N Eng J Med , vol.317 , pp. 1433-8
    • Williams, S.D.1    Stablein, D.M.2    Einhorn, L.H.3
  • 6
    • 11144355828 scopus 로고    scopus 로고
    • Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy
    • Stephenson AJ, Shariat SF, Zelefsky MJ et al. salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. JAMA 2004 291 : 1325 32
    • (2004) JAMA , vol.291 , pp. 1325-32
    • Stephenson, A.J.1    Shariat, S.F.2    Zelefsky, M.J.3
  • 7
    • 33746736194 scopus 로고    scopus 로고
    • Salvage radiotherapy for isolated prostate specific antigen increase after radical prostatectomy. evaluation of prognostic factors and creation of a prognostic scoring system
    • Buskirk SJ, Pisansly TM, Schild SE et al. Salvage radiotherapy for isolated prostate specific antigen increase after radical prostatectomy. evaluation of prognostic factors and creation of a prognostic scoring system. J Urol 2006 176 : 985 90
    • (2006) J Urol , vol.176 , pp. 985-90
    • Buskirk, S.J.1    Pisansly, T.M.2    Schild, S.E.3
  • 8
    • 33751018522 scopus 로고    scopus 로고
    • Adjuvant radiotherapy for pathologically advanced prostate cancer
    • Thompson I, Tangen CM, Paradelo J et al. Adjuvant radiotherapy for pathologically advanced prostate cancer. JAMA 2006 296 : 2329 35
    • (2006) JAMA , vol.296 , pp. 2329-35
    • Thompson, I.1    Tangen, C.M.2    Paradelo, J.3
  • 9
    • 15044353361 scopus 로고    scopus 로고
    • Contemporary survival results and the role of radiation therapy in patients with node negative seminal vesicle invasion following radical prostatectomy
    • Eggener SE, Roehl KA, Smith ND et al. Contemporary survival results and the role of radiation therapy in patients with node negative seminal vesicle invasion following radical prostatectomy. J Urol 2005 173 : 1150 5
    • (2005) J Urol , vol.173 , pp. 1150-5
    • Eggener, S.E.1    Roehl, K.A.2    Smith, N.D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.